Ceragon (CRNT) Q4 2025 earnings review
A Pivot Point: India Reset, North America Rising
Ceragon's Q4 concluded a challenging 'reset' year where revenue contracted 14% annually (23% in Q4) due to a massive slowdown in India. However, the narrative has shifted: North America has overtaken India as the largest region, fueled by private networks and 5G demand. While Q4 financials were soft (revenue $82.3M, barely breakeven GAAP Net Income), the forward indicators are bullish. Management flagged that North American backlog entering 2026 is 'nearly double' the prior year, supporting FY26 guidance that implies a return to ~9% growth.
🐂 Bull Case
The geographic mix has structurally improved. North America grew to 39% of Q4 revenue (vs 12% a year ago), supported by a backlog that has nearly doubled entering 2026. This region generally carries better margins and stability than India.
Management guided FY26 revenue to $355-$385M. The midpoint ($370M) implies a 9% rebound after the 14% decline in FY25, signaling the bottom is in.
🐻 Bear Case
India revenue collapsed from ~52% of the mix in 24Q4 to 30% in 25Q4. While management claims it is 'stable,' the lack of a strong recovery here puts intense pressure on North America to carry the growth story.
GAAP Net Income was effectively zero ($0.1M) in Q4, and the company posted a full-year GAAP loss of $2.1M. The divergence between GAAP and Non-GAAP ($8.2M FY profit) remains significant, driven largely by stock comp and amortization.
⚖️ Verdict: ⚪
Neutral/Positive. The financials are ugly on a YoY basis, but the strategic rotation toward North America and the doubling of backlog there validates the turnaround thesis. FY26 guidance suggests the worst is over.
Key Themes
Massive Geographic Rotation
The company has fundamentally swapped its growth engine. In Q4 2024, India was the dominant force (52% of revenue). In Q4 2025, North America took the lead (39% vs India's 30%). This reduces reliance on the volatile Indian carrier market and pivots exposure to higher-value North American private networks and 5G.
Backlog Strength
Management explicitly stated that 'backlog entering 2026 is nearly double what it was entering 2025' for North America. This is a hard data point that underpins the credibility of the FY26 growth guidance.
Operating Leverage Compression
Despite the 'in-line' results, operating leverage has deteriorated. In FY24, $394M revenue generated $38.7M GAAP Op Income (9.8% margin). In FY25, $338.7M revenue generated only $7.2M GAAP Op Income (2.1% margin). The fixed cost base remains high relative to the current revenue run-rate.
Balance Sheet Improvement
Despite the P&L challenges, cash generation improved. Net cash position rose to $19.4M at year-end 2025, nearly doubling from $10.1M in 2024. This was driven by disciplined working capital management, particularly inventory reduction.
Currency Headwinds impacting Margins
The FY26 margin outlook (6.5%-7.5% Non-GAAP) reflects 'currency assumptions established in January.' Given the volatility in global markets, specifically regarding the Shekel and Indian Rupee, FX remains a risk factor that could erode the guided thin margins.
Other KPIs
Stable. Down slightly from 34.0% in 24Q4. The shift to North America (typically higher margin) helped offset the volume loss, preventing a steeper decline.
Cash and equivalents rose $3M sequentially in Q4 to $38.4M. Management cited 'strong free cash flow' in the quarter, largely due to collections (Receivables dropped significantly from $149M a year ago to $99M).
Decelerating/Stabilizing. Down ~55% from the $55.6M peak in 24Q4. However, it was 'stable sequentially from Q3 2025,' suggesting the bleeding has stopped.
Guidance
Reversing. After a 14% decline in FY25, the midpoint ($370M) implies ~9.2% YoY growth. This confirms the company views FY25 as the cyclical trough.
Stable/Improving. The midpoint (7.0%) compares to 5.3% achieved in FY25 (Non-GAAP Op Income $18M / Revenue $338M). This implies stronger profitability on higher volume.
Key Questions
North America Backlog Conversion
You cited North America backlog is double that of the prior year. What is the expected conversion timeline? Is this H1 weighted, or evenly spread through FY26?
India Recovery Cadence
With India stabilizing sequentially in Q4, does the FY26 guidance assume a return to growth in India, or is the guide comprised entirely of North American expansion?
Gross Margin vs Mix
With North America now your largest region (39%), why isn't there more significant uplift in Gross Margins (stuck in mid-33s)? Are there pricing pressures in the private network segment offsetting the regional mix benefit?